Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inari Medical, Inc. (NARI)
NASDAQ:NARI
Inari Medical (NARI) Stock Price & Analysis
292 Followers
NARI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$36.73 - $71.85
Previous Close$45.75
Volume887.81K
Average Volume (3M)1.42M
Market Cap
$2.66B
Enterprise Value$2.34B
Total Cash (Recent Filing)$351.30M
Total Debt (Recent Filing)$32.26M
Price to Earnings (P/E)-111.8
Beta0.92
Next Earnings
Jul 31, 2024EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding58,138,159
10 Day Avg. Volume978,723
30 Day Avg. Volume1,419,401
Standard Deviation0.13
R-Squared0.13
Alpha-0.00642
Financial Highlights & Ratios
Price to Book (P/B)26.68
Price to Sales (P/S)6.94
Price to Cash Flow (P/CF)54.30
P/FCF Ratio53.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.99
Enterprise Value/Gross Profit6.91
Enterprise Value/Ebitda211.20
Forecast
1Y Price Target
$64.50Price Target Upside40.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Inari Medical News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalyst recommends the stock as Inari's attractive valuation coupled with a strong revenue growth trajectory presents a compelling investment opportunity.
Leadership And StrategyTim Benner's appointment as SVP of Sales is a strategic enhancement, positioning Inari to effectively navigate its next phase of international market expansion.
Market GrowthInari is poised for growth with a robust product pipeline and plans to expand beyond the US, tapping into the global mechanical thrombectomy market.
Bears Say
Financial PerformanceNARI's net loss per share of $0.08 was worse than consensus EPS estimate of $0.01 and the $0.04 EPS estimate.
Legal ConcernsReceived a civil investigative demand (CID) from the DOJ, outcome cannot be accurately predicted.
Market Share And CompetitionNARI is ceding market share in the PE and DVT markets to competition, suggesting that the company is growing at a slower rate despite the overall market growth.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NARI FAQ
What was Inari Medical, Inc.’s price range in the past 12 months?
Inari Medical, Inc. lowest stock price was $36.73 and its highest was $71.85 in the past 12 months.
What is Inari Medical, Inc.’s market cap?
Currently, no data Available
When is Inari Medical, Inc.’s upcoming earnings report date?
Inari Medical, Inc.’s upcoming earnings report date is Jul 31, 2024 which is in 73 days.
How were Inari Medical, Inc.’s earnings last quarter?
Inari Medical, Inc. released its earnings results on Apr 30, 2024. The company reported -$0.221 earnings per share for the quarter, missing the consensus estimate of -$0.157 by -$0.064.
Is Inari Medical, Inc. overvalued?
According to Wall Street analysts Inari Medical, Inc.’s price is currently Undervalued.
Does Inari Medical, Inc. pay dividends?
Inari Medical, Inc. does not currently pay dividends.
What is Inari Medical, Inc.’s EPS estimate?
Inari Medical, Inc.’s EPS estimate is -$0.2.
How many shares outstanding does Inari Medical, Inc. have?
Inari Medical, Inc. has 58,138,160 shares outstanding.
What happened to Inari Medical, Inc.’s price movement after its last earnings report?
Inari Medical, Inc. reported an EPS of -$0.221 in its last earnings report, missing expectations of -$0.157. Following the earnings report the stock price went up 11.409%.
Which hedge fund is a major shareholder of Inari Medical, Inc.?
Among the largest hedge funds holding Inari Medical, Inc.’s share is Slate Path Capital LP. It holds Inari Medical, Inc.’s shares valued at 27M.
---
Inari Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$64.50 (40.98% Upside)
$64.50 (40.98% Upside)
Blogger Sentiment
Bullish
NARI Sentiment 83%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 373.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-33.63%
12-Months-Change
Fundamentals
Return on Equity
-5.41%
Trailing 12-Months
Asset Growth
30.65%
Trailing 12-Months
Company Description
Inari Medical, Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States.
---
NARI Company Deck
---
NARI Earnings Call
Q1 2024
0:00 / 0:00
---
NARI Revenue Breakdown
96.48% VTE
3.52% Emerging Therapies
---
NARI Stock 12 Month Forecast
Average Price Target
$64.50
▲(40.98% Upside)
Technical Analysis
Best Analysts Covering NARI
1 Year
1 Year Success Rate
6/18 ratings generated profit
1 Year Average Return
-2.03%
reiterated a buy rating 8 days ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -2.03% per trade.
---